Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03537768 · ClinicalTrials.gov registry record · Phase 4
Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg
A Phase 4 study, sponsored by Kimberly Myer.
- Terminated
- Registry status
- Phase 4
- Development phase
- 532
- Enrollment target
NCT03537768 is a Phase 4 study that was terminated before completion, run by Kimberly Myer. The registered enrollment target is 532 participants.
The verdict
NCT03537768, a Phase 4 study, was terminated before completion, sponsored by Kimberly Myer.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 532 participants
- Enrollment target
Study Summary
The proposed research study is a Phase IIb, multi-center, single-blind, randomized study of UPA 30 mg, LNG 1.5 mg and LNG 3.0 mg to evaluate EC effectiveness in women with weight ≥ 80 kg who present within 72 hours of unprotected intercourse.
Interventions
- DRUG Ulipristal Acetate
- DRUG Levonorgestrel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 532 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2022-04-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03537768
The ClinicalTrials.gov registry entry for NCT03537768 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 532 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kimberly Myer, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ulipristal Acetate is the first listed.
NCT03537768 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03537768 about?
NCT03537768 is a clinical study titled "Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg". The proposed research study is a Phase IIb, multi-center, single-blind, randomized study of UPA 30 mg, LNG 1.5 mg and LNG 3.0 mg to evaluate EC effectiveness in women with weight ≥ 80 kg who present within 72 hours of unprotected intercourse.
What is the current status of trial NCT03537768?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 532 participants. The study started on 2018-07-12. Estimated completion is 2022-04-20.
What interventions are being tested in trial NCT03537768?
The interventions under investigation include: Ulipristal Acetate (DRUG), Levonorgestrel (DRUG).
Who is sponsoring clinical trial NCT03537768?
This trial is sponsored by Kimberly Myer, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.